2014
MicroRNAs Involved in the Lipid Metabolism and Their Possible Implications for Atherosclerosis Development and Treatment
NOVÁK, Jan, Julie BIENERTOVÁ VAŠKŮ, Tomáš KÁRA a Miroslav NOVÁKZákladní údaje
Originální název
MicroRNAs Involved in the Lipid Metabolism and Their Possible Implications for Atherosclerosis Development and Treatment
Autoři
NOVÁK, Jan (203 Česká republika, garant, domácí), Julie BIENERTOVÁ VAŠKŮ (203 Česká republika, domácí), Tomáš KÁRA (203 Česká republika) a Miroslav NOVÁK (203 Česká republika)
Vydání
Mediators of Inflammation, New York, Hindawi Publishing Corporation, 2014, 0962-9351
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30105 Physiology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.236
Kód RIV
RIV/00216224:14110/14:00075532
Organizační jednotka
Lékařská fakulta
UT WoS
000335329700001
Klíčová slova anglicky
microRNA; lipid metabolism; atherosclerosis; circulating microRNA
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 1. 2015 17:07, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Hyperlipidemia is a well-accepted risk factor in the development of atherosclerosis. MicroRNAs (miRNAs), a novel class of posttranscriptional regulators of gene expression, are involved in a variety of biological and pathological processes, including the regulation of the lipid metabolism and atherosclerosis. As our knowledge of miRNAs expands, a new class of "circulating miRNAs" has recently been described. It includes miRNAs which may be found in various bodily fluids packaged in microvesicles/exosomes, or bound to specific transporting proteins. High-density lipoprotein (HDL) particles have been identified as one such carrier. As this class of miRNAs likely plays a role in intercellular communication, it may also contribute to the atherosclerosis development and progression. This review aims to provide a comprehensive explanation of the roles of distinct miRNAs involved in the regulation of the lipid metabolism. These microRNAs seem to be promising therapeutic agents, as documented in rodents and African green monkeys. The second part of the review focuses on circulating miRNAs and their involvement in the atherosclerosis, especially as their levels have been described as altered in patients with dyslipidemia/hyperlipidemia. Special emphasis is placed on miRNAs transported in a complex with HDL particles and on those which may be considered potential atherosclerosis biomarkers.
Návaznosti
MUNI/A/0957/2013, interní kód MU |
|